TuHURA Biosciences (HURA) Receivables (2011 - 2015)

TuHURA Biosciences' (HURA) quarterly Receivables came in at $25831.0 in Q2 2015, up 169.86% year-on-year from $9572.0 in Q2 2014, and up 33.56% quarter-over-quarter from $19340.0 in Q3 2014.

TuHURA Biosciences (HURA) Receivables (2011 - 2015) Analysis & Trends

TuHURA Biosciences' Receivables history runs 4 years deep, the most recent figure standing at $25831.0 for Q2 2015.

  • On a quarterly basis, Receivables rose 169.86% year-over-year to $25831.0 in Q2 2015; TTM through Jun 2015 was $25831.0, a 169.86% increase from a year earlier, with the FY2015 full-year figure at $25831.0, up 169.86% from the prior year.
  • Receivables improved to $25831.0 in Q2 2015 per HURA's latest filing, from $19340.0 in the prior quarter.
  • Across five years, Receivables topped out at $45499.0 in Q4 2012 and bottomed at $5000.0 in Q2 2011.
  • The 4-year median for Receivables is $19340.0 (2014), against an average of $21048.4.
  • Biggest YoY gain for Receivables was 169.86% in 2015; the steepest drop was 169.86% in 2015.
  • Year by year, Receivables stood at $5000.0 in 2011, then surged by 809.98% to $45499.0 in 2012, then plunged by 57.49% to $19340.0 in 2014, then soared by 33.56% to $25831.0 in 2015.
  • Per Business Quant, the three latest HURA Receivables figures stand at $25831.0 (Q2 2015), $19340.0 (Q3 2014), and $9572.0 (Q2 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 4.97 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 938.02 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 TuHURA Biosciences 132.62 Mn 132.62 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2015 25,831.00
Sep 30, 2014 19,340.00
Jun 30, 2014 9,572.00
Dec 31, 2012 45,499.00
Jun 30, 2011 5,000.00